UNSPSC 51312300: Antihistamine or H1 blocker ethylamines

Antihistamine or H1 blocker drugs made from ethanamine or CH3CH2NH2.

UNSPSC 51312300 Antihistamine or H1 blocker ethylamines is a Class code that, in recent state and local procurement, covers the procurement of pharmaceutical and over-the-counter health products through multiple channels including direct purchase, cooperative agreements, and prescription-fulfillment programs. State and local governments procure under this code through county health departments, state health and human services agencies, and multistate cooperative purchasing alliances to support community health initiatives, employee health plans, and pharmacy benefit programs. The issuing bodies span individual counties (Seminole County, Florida), state agencies (Texas Health and Human Services Commission), and cooperative purchasing organizations (Minnesota Multistate Cooperative Purchasing Alliance serving multiple states including Oregon). The nature of solicitations ranges from direct product procurement with quarterly delivery schedules to strategic vendor information-gathering and cooperative framework agreements that establish pricing and distribution channels across multiple government jurisdictions.

Recent activity appears across Florida, Texas, and Minnesota-based cooperative coverage. Seminole County issued IFB 60459723LAS in June 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building and a response deadline of July 26, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, to gather vendor capabilities on direct-to-manufacturer prescription programs that bypass traditional pharmacy benefit managers and wholesalers—a preliminary market-intelligence phase preceding formal procurement. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities, with a March 26, 2026 response deadline and July 1, 2026 contract effective date; this procurement requires vendors to maintain relationships with authorized wholesalers (AmerisourceBergen, Cardinal Health, Morris & Dickson) and comply with cGMP and DSCSA certification, with evaluation weighted 75 percent on price competitiveness and 25 percent on administrative compliance and data-format requirements.